These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 1380064)

  • 21. Eotaxin and RANTES enhance 5-oxo-6,8,11,14-eicosatetraenoic acid-induced eosinophil chemotaxis.
    Powell WS; Ahmed S; Gravel S; Rokach J
    J Allergy Clin Immunol; 2001 Feb; 107(2):272-8. PubMed ID: 11174193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mast cell chemotactic activity of RANTES.
    Mattoli S; Ackerman V; Vittori E; Marini M
    Biochem Biophys Res Commun; 1995 Apr; 209(1):316-21. PubMed ID: 7537040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RANTES augments radical oxygen products from eosinophils.
    Chihara J; Hayashi N; Kakazu T; Yamamoto T; Kurachi D; Nakajima S
    Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):52-3. PubMed ID: 7512397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokines, chemokines, RANTES, and eotaxin.
    Graziano FM; Cook EB; Stahl JL
    Allergy Asthma Proc; 1999; 20(3):141-6. PubMed ID: 10389546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of chemokines such as RANTES in allergic disease].
    Chihara J
    Rinsho Byori; 1998 Aug; 46(8):816-20. PubMed ID: 9760835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine.
    Dahinden CA; Geiser T; Brunner T; von Tscharner V; Caput D; Ferrara P; Minty A; Baggiolini M
    J Exp Med; 1994 Feb; 179(2):751-6. PubMed ID: 7507512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotactic agonists induce cytokine generation in eosinophils.
    Miyamasu M; Hirai K; Takahashi Y; Iida M; Yamaguchi M; Koshino T; Takaishi T; Morita Y; Ohta K; Kasahara T
    J Immunol; 1995 Feb; 154(3):1339-49. PubMed ID: 7529800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A549 cells can express interleukin-16 and stimulate eosinophil chemotaxis.
    Cheng G; Ueda T; Eda F; Arima M; Yoshida N; Fukuda T
    Am J Respir Cell Mol Biol; 2001 Aug; 25(2):212-8. PubMed ID: 11509331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of RANTES receptors on human monocytic cells: competition for binding and desensitization by homologous chemotactic cytokines.
    Wang JM; McVicar DW; Oppenheim JJ; Kelvin DJ
    J Exp Med; 1993 Mar; 177(3):699-705. PubMed ID: 7679707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes.
    Uguccioni M; D'Apuzzo M; Loetscher M; Dewald B; Baggiolini M
    Eur J Immunol; 1995 Jan; 25(1):64-8. PubMed ID: 7531149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucocorticoid inhibition of RANTES expression in human lung epithelial cells.
    Kwon OJ; Jose PJ; Robbins RA; Schall TJ; Williams TJ; Barnes PJ
    Am J Respir Cell Mol Biol; 1995 May; 12(5):488-96. PubMed ID: 7537968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T cell, and macrophage recruitment.
    Ying S; Taborda-Barata L; Meng Q; Humbert M; Kay AB
    J Exp Med; 1995 Jun; 181(6):2153-9. PubMed ID: 7539041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of RANTES on intracellular expression of EG2 antigen in eosinophils.
    Kakazu T; Chihara J; Saito A; Higashimoto I; Yamamoto T; Kurachi D; Nakajima S
    Int Arch Allergy Immunol; 1995; 108 Suppl 1():43-4. PubMed ID: 7549521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of eosinophil chemotaxis and function in Taenia taeniaeformis infections in the laboratory rat.
    Potter K; Leid RW
    Vet Parasitol; 1986 Mar; 20(1-3):103-16. PubMed ID: 3518212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES.
    Lim KG; Wan HC; Bozza PT; Resnick MB; Wong DT; Cruikshank WW; Kornfeld H; Center DM; Weller PF
    J Immunol; 1996 Apr; 156(7):2566-70. PubMed ID: 8786320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration.
    Rand TH; Cruikshank WW; Center DM; Weller PF
    J Exp Med; 1991 Jun; 173(6):1521-8. PubMed ID: 1851800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES.
    Ebisawa M; Yamada T; Bickel C; Klunk D; Schleimer RP
    J Immunol; 1994 Sep; 153(5):2153-60. PubMed ID: 7519642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eosinophil chemotactic lymphokine produced by spleen cells of Schistosoma japonicum-infected mice. II. Physicochemical heterogeneity of eosinophil chemotactic lymphokines selective to bone marrow- or peritoneal exudate-eosinophils.
    Owhashi M; Nawa Y
    Int Arch Allergy Appl Immunol; 1987; 83(3):290-5. PubMed ID: 3110075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eosinophil recruitment following allergen challenge is associated with the release of the chemokine RANTES into asthmatic airways.
    Teran LM; Noso N; Carroll M; Davies DE; Holgate S; Schröder JM
    J Immunol; 1996 Aug; 157(4):1806-12. PubMed ID: 8759771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotactic heterogeneity of eosinophils in Kimura's disease.
    Saita N; Ueno M; Yoshida M; Kimura T; Ando M; Hirashima M
    Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):21-3. PubMed ID: 8155998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.